The short version
World Obesity Day falls on the 4th of March each year. This year we are returning to it during Neurodiversity Celebration Week, because the two conversations share more than might be immediately obvious. Both are about conditions that have long been attributed to personal failing rather than biology. Both carry a history of stigma that medicine is still working to undo. The global estimate currently stands at more than one billion people living with obesity, with projections suggesting that number will reach four billion by 2035. This article is about what the shifting medical understanding of obesity means, and what it might mean for people who have been carrying this condition for a long time.
World Obesity Day and Neurodiversity Celebration Week
World Obesity Day was established by the World Obesity Federation as a global call to action: to improve policies, share understanding, and change the way obesity is treated across health systems and in the wider culture. It falls on the 4th of March each year. We are publishing this a few weeks later, during Neurodiversity Celebration Week, and the timing feels fitting rather than incidental.
Neurodiversity Celebration Week exists to challenge the stereotypes and misconceptions that have historically made life harder for people with neurological differences. It asks that we look at conditions like ADHD, autism, and dyslexia through a biological lens rather than a moral one. That reframing, from personal failing to physiological reality, is exactly the same shift that obesity medicine has been working toward for decades.
The people who struggle most with weight management are often the same people who have been told, in various clinical and cultural settings, that the problem is a lack of effort or discipline. That message is wrong in obesity. It is wrong in neurodivergent conditions. And it does real harm in both. This week, as we celebrate neurological difference and the people who live with it, I want to make the case for extending that same generosity of understanding to the complexity of obesity.
I find World Obesity Day useful as a point of reflection, both as a clinician and as someone who has spent over twenty years sitting with patients in the midst of this. The statistics are striking. But the more important thing, for me, is what lies behind them. The years of trying. The consultations that ended in generic advice. The shame that built up quietly alongside the weight.
If that description is familiar to you, this article is for you.
Obesity Is A Chronic Medical Condition
The World Health Organisation, the Lancet Diabetes and Endocrinology Commission, and major obesity medicine bodies worldwide now recognise obesity as a chronic, relapsing medical condition with complex biological underpinnings. It sits in genetics, in the hormonal systems that regulate hunger and appetite, in the neurological pathways that govern reward and satiety, and in the social and environmental conditions that shape what and how people eat.
A landmark Commission published in The Lancet Diabetes and Endocrinology in January 2025, led by 56 specialists and endorsed by more than 75 international medical organisations, defined clinical obesity as a chronic, systemic illness driven by excess adiposity and called for diagnostic and treatment frameworks that reflect that understanding (Rubino et al., 2025). This is not a fringe position. It is the current scientific consensus, and it is slowly making its way into clinical practice.
For people who have spent years in a medical system that responded to their weight with diet sheets and encouragement, this shift in framing is significant. The condition was always biological. What has changed is the willingness of medicine to say so clearly, and to develop treatments accordingly.
What Years Of Misunderstanding Obesity Costs
I want to say something carefully here, because I think it deserves to be said.
Many people living with obesity have spent years, sometimes decades, receiving care that was shaped more by moral assumption than medical evidence. The advice given was often well-meaning. But the underlying message, delivered in clinical rooms and in the broader culture, was that weight was a matter of discipline. That if a person simply made better choices, the problem would resolve.
The research tells a different story. A comprehensive review in the New England Journal of Medicine documented the powerful physiological responses that the body mounts against sustained weight loss, including hormonal adaptations that increase appetite and reduce energy expenditure, sometimes persisting for years after weight is lost (Sumithran et al., 2011). These are not signs of failure. They are signs of a chronic condition behaving as chronic conditions do.
The cost of years of misunderstanding is not abstract. It shows up in the clinic as patients who have internalised blame that was never theirs to carry, who approach treatment with exhaustion rather than hope, who have learned to expect disappointment. Rebuilding from that place is part of the clinical work, and it takes time.
The Turning Point In Obesity Treatment
Something meaningful has changed in the treatment landscape for obesity over the past decade, and particularly in the last few years.
The development of GLP-1 receptor agonists, a class of medications that work on the hormonal systems governing appetite and satiety, has been one of the most significant advances in obesity medicine in a generation. Clinical trials have demonstrated substantial and sustained weight loss outcomes, with reductions in cardiovascular risk and improvements in metabolic health that go well beyond what calorie restriction alone can achieve (Wilding et al., 2021). These medications work with the biology of the condition rather than against it.
Alongside medication, the broader model of care in obesity medicine has evolved. Multidisciplinary approaches, combining medical management with dietitian support, exercise physiology, and behavioural coaching, produce better outcomes than any single intervention in isolation. The focus has shifted from weight as the sole target to metabolic health, body composition, function, and quality of life as the measures that matter.
I built Alevia because I wanted to practise in this model. The approach here is structured, evidence-based, and genuinely personalised. Every patient receives a thorough clinical assessment, not a generic plan handed across a desk.
For People Who Have Been Struggling With Obesity For A Long Time
If you have been living with obesity for many years, the history of your experience with the medical system probably carries some weight of its own. You may have been advised to do things that did not work, not because you did not follow the advice, but because the advice was not calibrated to the biology of your condition.
The treatments that now exist are meaningfully different from what was available even five years ago. GLP-1 medications, carefully managed and monitored, can change the hormonal landscape in ways that make sustained weight management possible for people who have found previous efforts difficult to maintain. The response varies between individuals, and clinical assessment is essential before starting any treatment. But the options are real and the evidence is solid.
What I want people who have struggled for a long time to hear is this: the difficulty was never a character flaw. The condition was always complex. And the care available now is genuinely better than what came before.
If you have given up on seeking help, I understand why. And I would gently suggest that the landscape has changed enough to be worth another look.
What Good Obesity Care Looks Like
In my view, good obesity care begins with being taken seriously. A proper clinical history. An assessment of the biological factors at play, including hormones, metabolic health, sleep, and medications that may be contributing to weight gain. Body composition measured over time, so that progress can be tracked in ways that go beyond the scale.
It involves a treating team that communicates across disciplines. A doctor who understands obesity medicine. A dietitian who works with the practical realities of how people eat, not an idealised version of how they should. An exercise physiologist who builds a programme around what a person can actually do. And the kind of ongoing support that reflects what we know about chronic conditions: that they require long-term management, not a one-time intervention.
It also involves, I think, a clinical relationship built on respect. Obesity has been medically mismanaged for long enough that patients often arrive carrying the expectation of judgement. The work of a good clinician in this space includes undoing some of that, creating enough safety for honest conversation about what is actually going on.
This article is general information and not personal medical advice. Treatment decisions should be made in consultation with a qualified health professional. Individual suitability varies and requires clinical assessment.
Looking Forward
On World Obesity Day, I think about the people I have had the privilege of sitting with over twenty years of clinical practice. People who came in having tried hard and been told, explicitly or implicitly, that trying harder was the answer. People who arrived exhausted.
Medicine has caught up with what those patients always deserved: a framework that recognises the complexity of what they are managing, treatments that engage with the biology of the condition, and care that holds them with dignity throughout.
There is more work to do. The stigma that surrounds obesity does not disappear because the science has changed. Changing culture takes longer than changing guidelines. But I am more optimistic about the treatment landscape for obesity than I have been at any other point in my career, and I hold that optimism alongside the people it is for.
If today is the day you decide to ask for help, we are here.
Evidence Notes
Rubino, F., et al. (2025). Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes and Endocrinology, 13(3), 221-262. https://doi.org/10.1016/S2213-8587(24)00316-4
Sumithran, P., et al. (2011). Long-term persistence of hormonal adaptations to weight loss. New England Journal of Medicine, 365(17), 1597-1604. https://pubmed.ncbi.nlm.nih.gov/22029981/
Wilding, J.P.H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
World Obesity Federation. (2023). World Obesity Atlas 2023. https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023
